Further experiments reveal that the addition of a Wnt/β‐catenin activator (CHIR99021) induces the expression of β‐catenin and Met and increases the proliferative and invasive capacities of control medium‐treated glioma cells but not those of hNSC‐CM‐treated glioma cells. Here, MET is linked to central nervous system cancer.